Joint statement on the need for improved protection and prevention for immunocompromised patients in the context the COVID-19 pandemic, European Society for Organ Transplant (ESOT)

On June 15, 2022 the European Society for Organ Transplant (ESOT), issued a joint statement together with the European Kidney Health Alliance (EKHA), European Cancer Patients Coalition (ECPC) and Union Therapeutics calling on the European Commission, Parliament, and the Council to fully integrate the systematic protection of immunocompromised patients in their response and preparedness efforts against the current and future health crises such as the next infectious disease outbreak.

ESOT points out that there are 14.5 million estimated immunocompromised people across the EU and they suffer from lower vaccine efficacy than the general population. Only through a long-term and systematic approach with a particular emphasis on prevention against infections, the joint statement reads, will the EU be able to deliver a truly equitable health strategy to protect all its citizens.f recommendations to follow until more complete data are available.

The Joint Statement can be dowloaded at this link on the ESOT website

Scroll to Top